Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

DJO Invests in Next-Generation Augmented Reality Technology Primed for ASC Market Growth


DJO has announced a strategic investment in Insight Medical Systems, a technology company dedicated to wearable surgical navigation in orthopaedics. Insight’s flagship product, ARVIS* (Augmented Reality Visualization and Information System), will combine tracking cameras with both a 3D display and handsfree interface in an integrated eyepiece for total joint arthroplasty. Unlike other augmented reality (AR) platforms, ARVIS is the first system with proprietary hardware designed to assist arthroplasty surgeons in enhancing component positioning precision to improve joint arthroplasty outcomes.

The Computer Assisted Surgery (CAS) Technology market is growing at a compound annual growth rate (CAGR) of 32%[1]. Similarly, the shift in the site of care from hospitals to ambulatory surgery centers (ASCs) is expanding rapidly. If half of routine total joint cases were done in the ASC, UnitedHealth Group quantified this shift as having the potential to help 500,000 patients avoid overnight hospital stays and save $3B annually[2]. As surgeons look to incorporate technology into their surgical workflows whether at the hospital or ASC, the discussion often focuses on balancing the clinical benefit of a technology with the added time and cost associated with it. The high acquisition cost of current CAS systems can include a capital-intensive investment as well as per-case disposables and service contracts. These costs, along with the large footprint of technologies like robotics, are particularly restricting for ASCs.

“DJO has been partnering with the orthopaedic surgeon community to understand their technology needs across all anatomies and in all settings in which they operate,” said Louis Vogt, president and general manager of DJO Surgical. “The Insight team has developed an impressive 3D AR technology that tracks the surgeon’s viewpoint and delivers navigation and patient-specific information right at the surgical site in a highly efficient and seamless workflow. ARVIS complements DJO’s ASC 360 solutions and adds to our full range of implant technologies, surgical tools and digital care solutions that uniquely span the continuum of care.”

“We’re thrilled to partner with a leading MedTech company that has an impressive growth trajectory,” said Nick van der Walt, CEO of Insight. “DJO and Insight have a shared vision of improving clinical outcomes with technology in a streamlined, cost-effective way. We will build on the current capabilities of ARVIS in knee and hip arthroplasty and expand to other indications in orthopedics.”

For ease of use, the ARVIS system will be compatible with existing surgical helmets and a single tray of trackable instruments eliminates the need for disposables. Insight will leverage DJO’s sales channel to launch ARVIS in the second half of this year. The EMPOWR Partial, Primary and Complex Primary Knee and Hip implant systems will be compatible. The EMPOWR portfolio is the culmination of research, clinical legacy and material technologies that have resulted in hip and knee products that help restore healthy kinematics and provide surgical efficiencies optimized for today’s health care environment. Driven by premium, intelligently designed single-tray instrumentation, these implant systems have up to a 50% reduction in storage and sterilization costs compared to similar products on the market[3].

For information about DJO, visit

For information about Insight, visit

* ARVIS is pending clearance by the FDA. ARVIS is a registered trademark of Insight Medical Systems.


1. SmartTrak Computer Assisted Surgery Revenue projections:
3. Based on calculation of no. of trays compared to DePuy Pinnacle and Zimmer Biomet G7. for cost of sterilization
Based on calculation of no. of trays compared to Oxford Uni Knee.




Submit a Comment

Your email address will not be published. Required fields are marked *